Ultrastructural alterations induced by 1-methyl-4-phenylpyridinium (MPP+) in canine substantia nigra and rat mesencephalon in vitro

This publication has 17 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
  Biochemical and Biophysical Research Communications, 1985
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
  Proceedings of the National Academy of Sciences, 1985
• 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Destroys Dopamine Neurons in Explants of Rat Embryo Mesencephalon
  Science, 1984
• 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra
  Neuroscience Letters, 1984
• Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
  Science, 1984
• Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
  European Journal of Pharmacology, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• The development of the dog nigrostriatal system in organotypic culture
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981